Skip to Main Content

Paper Details

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031).
Clin Cancer Res
5
2022
Author NameAffiliation
Vera J SumanMayo Clinic
Tanya L HoskinMayo Clinic
Meenakshi AnuragBaylor College of Medicine/Dan L. Duncan Comprehensive Cancer Center
Cynthia X MaWashington University School of Medicine in St. Louis
Kelly K HuntThe University of Texas MD Anderson Cancer Center
Kelly K HuntThe University of Texas MD Anderson Cancer Center
Matthew J EllisBaylor College of Medicine/Dan L. Duncan Comprehensive Cancer Center
William F SymmansThe University of Texas MD Anderson Cancer Center
  • 1 - 8

Datasets

Release 1.2